Predictors of adalimumab drug survival in psoriasis differ by reason for discontinuation: long‐term results from the Bio‐CAPTURE registry

By  

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY & VENEREOLOGY, Vol. 29, Iss. 3, 2015-03 ,pp. : 560-565

John Wiley & Sons Inc

Access to resources Recommend Favorite

Clinical similarity of the biosimilar ABP 501 compared with adalimumab after single transition: long‐term results from a randomized controlled, double‐blind, 52‐week, phase III trial in patients with moderate‐to‐severe plaque psoriasis

By  

BRITISH JOURNAL OF DERMATOLOGY, Vol. 177, Iss. 6, 2017-12 ,pp. : 1562-1574

John Wiley & Sons Inc

Access to resources Recommend Favorite

Changes in bone mineral density during long-term treatment with adalimumab in patients with rheumatoid arthritis: a cohort study

By Krieckaert Charlotte L. M.  

British Journal of Rheumatology , Vol. 52, Iss. 3, 2013-03 ,pp. : 547-553

Oxford University Press

Access to resources Recommend Favorite

Efficacy and tolerability of a 5% lidocaine medicated plaster for the topical treatment of post-herpetic neuralgia: results of a long-term study*

By Hans Guy   Sabatowski Rainer   Binder Andreas   Boesl Irmgard   Rogers Peter   Baron Ralf  

Current Medical Research and Opinion, Vol. 25, Iss. 5, 2009-05 ,pp. : 1295-1305

Informa Healthcare

Access to resources Recommend Favorite

Long-Term Results of the Immunosuppressive Treatment of Patients with Severe Acquired Aplastic Anemia: A Single Institution Study

By  

Acta Haematologica, Vol. 110, Iss. 4, 2003-12 ,pp. : 184-187

Karger

Access to resources Recommend Favorite